SCRI Oncology Partners - PPDS

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Childhood cancers1 trial
• Colorectal cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 1/22 trials
• Phase 11 trial

Status

• Recruiting2 trials
• Withdrawn1 trial

Lead sponsor

• IDEAYA Biosciences1 trial
• Pierre Fabre Medicament1 trial
• Recursion Pharmaceuticals Inc.1 trial

Running trials

• Recruiting

  A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

  NCT07540572· Phase 1· IDEAYA Biosciences· Source

  Contact: Connor Frost

• Recruiting

  First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

  NCT06043817· Phase 1/2· Pierre Fabre Medicament· Source

  Contact: Adele De MASSON, clinical development director, MD, PhD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer2 recruiting
• Colorectal cancer1 recruiting
• Prostate cancer1 recruiting

Closed trials

• Recruiting

  A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

  NCT06678659· Phase 1/2· Recursion Pharmaceuticals Inc.· Source